Enosium Life Science welcomes Sandrine Bourguignon, founder and CEO of Rweality

We are thrilled to welcome Sandrine Bourguignon as Chief Executive Officer (CEO) of Rweality and also assuming the role of CEO of Vyoo Agency at Enosium Life Science.

With over 20 years of experience as a Health Economist and Doctor in Public Health, Sandrine brings in-depth expertise in Market Access, health policies, and medical products and innovations assessment that plays a crucial role in supporting key areas of Enosium Life Science and its strategic growth.

Sandrine holds a Doctorate in Public Health with a specialisation in interventions and health economics from the University of Bordeaux, as well as a Master’s degree in Economics and Health Management from the University of Paris 7.

Throughout her career, Sandrine has held leadership roles in Real World Evidence (RWE), HealthEconomics and Outcomes Research (HEOR) and Market Access. Since 2008, she has also served as an associate lecturer at the University of Paris-Dauphine and gained valuable hospital-based experience.

Sandrine is a board member of the College of Health Economists (CES), serves on the Executive Committee of AFCROs (Association of CROs in France), and is a partner member of FIAC (Ai &oncology).